Inactive Instrument

Varian Medical Systems, Inc. Stock price

Equities

VAR

US92220P1057

Dynamic Chart
Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care CI
Varian Medical Systems, Inc. acquired Aspekt Solutions. CI
Varian Announces First Participant Treated in RADIATE-VT Clinical Trial of Cardiac Radioablation for Patients with Refractory Ventricular Tachycardia CI
Varian Collaborating with Nova Scotia Health to Transform Cancer Care CI
Varian Receives Investigational Device Exemption for Flash Technology Clinical Trial, FAST-02 CI
Adaptiiv Collaborates with HP and Varian to Enhance Personalization in Radiation Oncology with 3D Printed Medical Devices CI
Oulu University Hospital in Finland Enters Long-Term Strategic Partnership with Varian and Siemens Healthineers CI
Varian and Icon Oncology Partner to Establish Value-Based Cancer Treatment Hub for Southern Africa CI
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01, First Human Clinical Trial of FLASH Therapy for Cancer CI
Varian Medical Systems, Inc. Receives FDA "Breakthrough Device Designation" For Embozene® Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis CI
Elekta : Medical equipment maker Elekta sees higher supply chain costs, shares fall RE
Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian CI
Siemens : Targets Higher Full-Year Profit As Demand Surge Beats Supply Chain Woes MT
Siemens Backs Fiscal Year 2021 Outlook, Including Varian Deal DJ
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation System for Treatment of Refractory Ventricular Tachycardia (VT) CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 56 21-04-14
Corporate Officer/Principal - -
Members of the board TitleAgeSince
Director of Finance/CFO 56 21-04-14
Director/Board Member 58 21-04-14
More insiders
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, cardiac radioablation, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product. Through its subsidiary, Cooperative CL Enterprises, the Company distributes radiotherapy equipments in Taiwan.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock Varian Medical Systems, Inc. - Nyse
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer